Dr. Ikizler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Dr. Talat "Alp" Ikizler is the Director of the Division of Nephrology and Hypertension, Vice-Chair for Clinical
Research, Department of Medicine, Professor of Medicine, and Catherine McLaughlin
Hakim Chair in Vascular Biology at the Vanderbilt University School of Medicine
(VUSM) in Nashville, Tennessee. He specializes in hypertension, nutrition, general nephrology, acute renal failure, and chronic kidney disease. He completed both his residency in Internal Medicine and fellowship in Nephrology at the Vanderbilt University Medical Center. He has multiple notable publications which include topics on infection prevention in dialysis patients, impaired incretin homeostasis in non-diabetic moderate-severe chronic kidney disease, and the impact of a wearable activity tracker on patients in hemodialysis. He has performed clinical trials on nutrition, inflammation and insulin resistance in end-stage renal disease, and prevention and treatment of hemodialysis vascular access malfunction. Dr. Ikizler was honored as an Elected Member from The American Society for Clinical Investigation in 2005 and the Association of American Physicians in 2018.
Education & Training
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1997 - 1999
- Vanderbilt University Medical CenterFellowship, Nephrology, 1993 - 1996
- Istanbul University FomClass of 1987
Certifications & Licensure
- TN State Medical License 1996 - 2025
- AL State Medical License 2020 - 2020
- MI State Medical License 1995 - 1999
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2005
Clinical Trials
- Prevention and Treatment of Hemodialysis Vascular Access Malfunction Start of enrollment: 1998 May 01
- Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3 Start of enrollment: 2010 Jan 01
- Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease Start of enrollment: 2022 Mar 01
Publications & Presentations
PubMed
- The Association of Odor Identification With Nutritional Status and Systemic Inflammation in Patients With Advanced Chronic Kidney Disease.Ragibe Gulsah Dilaver, Andrew Guide, Robert Greevy, Talat Alp Ikizler, Ayse Zeynep Bal
Journal of Renal Nutrition. 2025-01-01 - Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKD.Armin Ahmadi, Jorge Gamboa, Jennifer E Norman, Bamba Enkhmaa, Madelynn Tucker
Clinical Journal of the American Society of Nephrology. 2025-01-01 - 1 citationsEffects of High Amylose-Resistant Starch on Gut Microbiota and Uremic Toxin Levels in Patients With Stage-G3a-G4 Chronic Kidney Disease: A Randomized Trial.Samuel A Headley, Donna J Chapman, Michael J Germain, Elizabeth E Evans, Karen L Madsen
Journal of Renal Nutrition. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: